Integrated Cognitive Assessment’s speed, ease of administration and lack of learning effect enable monitoring of NHS patients with mild cognitive…
Read More
Admission onto platform streamlines adoption of Integrated Cognitive Assessment technology by NHS organisations VANCOUVER, BC, Oct. 13, 2020 /CNW/ – Cognetivity Neurosciences…
Texas Medical Centre innovation program aims to accelerate market access to US healthcare system for visionary medical device and digital…
Company’s cognitive assessment platform being used in renowned specialist NHS mental health Trust to improve dementia assessment VANCOUVER, BC, Sept. 29,…
New results published at major dementia conference further validate company’s ICA platform’s capabilities and suitability for early disease detection VANCOUVER,…
We investigated the link between participant’s performance in ICA test and their cortical volume and thickness; we were further interested…
Electroencephalography (EEG) has been commonly used to measure brain alterations in the early stage of Alzheimer’s disease. However the reported…
The Integrated Cognitive Assessment (ICA) test is based on humans’ strong reaction to animal stimuli, and the ability of a…
VANCOUVER, May 26, 2020 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) today announced the…
Background: Cognitive impairment is common in patients with multiple sclerosis (MS). Accurate and repeatable measures of cognition have the potential…
